Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy
Clinical trial NCT06490068 · UNKNOWN
Trial details
- NCT number
- NCT06490068
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-04
- Primary completion
- 2026-03-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.